iRhythm Technologies, Inc.

iRhythm Technologies, Inc. is a digital healthcare company that develops wearable cardiac monitoring solutions for diagnosing heart arrhythmias. Founded in 2006 and listed on Nasdaq under the ticker IRTC, the company pairs continuous, high-quality ECG data capture with AI-driven analysis, working across AI and machine learning, deep learning, ECG and cardiac signal analysis, medical device engineering and wearable sensor technology.

Its Zio ECG monitor is a wearable, single-use ECG patch that patients wear for up to 14 days to capture continuous, high-quality ECG data. The iRhythm AI platform combines FDA-cleared AI algorithms with deep-learning technology and has been clinically proven to analyse heartbeat data as accurately as expert cardiologists. The company reports having served over 8 million patients and analysed more than 1.5 billion hours of heartbeat data.

iRhythm operates in the United States, the United Kingdom and Japan, within the digital healthcare, cardiology and cardiac monitoring, medical device and diagnostics sectors. It is led by CEO Quentin Blackford. The company describes its mission as innovating trusted solutions that detect, predict and prevent disease, with an emphasis on patient-friendly diagnostic experiences and on improving traditional cardiac monitoring that was uncomfortable, inconvenient and prone to missing critical data.